Study: PrEP, Taken Regularly, 100 Percent Effective

By BTL Staff

Scientists at the International AIDS Conference in Sydney, Australia, released the results of an open label study of Pre-Exposure Prophylaxis this week, which found that regular dosing of the drug Truvada is 100 percent effective in preventing HIV-negative people from becoming infected with the virus.

AIDS Map reports the study, released in The Lancelet medical journal in conjunction with the report on the study at the conference, found that people who had blood concentration levels equivalent to taking Truvada at least four times a week. That, researchers say, resulted in 100 percent protection from HIV infection.

The study did find adherence to taking the drugs was low - only one-third of participants had a blood level equal to four or more weekly doses. Adherence was also lower in younger men who have sex with men, a key demographic in need of the drug, experts from both the CDC and the World Health Organization have said.

Learn more at http://www.prep4itnow.com


  • Latest News

Enter To Win

Enter contests to win great prizes like CDs, DVDs, concert tickets and more

Special Section: Health and Wellness
Smoking Remains Critical Health Issue For LGBT Michiganders

MICHIGAN - A recent study by Affirmations Community Center and the Kalamazoo Gay and Lesbian Resource Center, funded by the Michigan Department of Community Health (MDCH), facilitated eight focus groups with LGBT-identified individuals that helps shed light on tobacco use within the LGBT community.

View More Health and Wellness
This Week's Issue

Download or view this week's print issue today!